FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q33385308> ?p ?o ?g. }

• Q33385308 description "2009 nî lūn-bûn" @default.
• Q33385308 description "2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած" @default.
• Q33385308 description "2009 թվականի հուլիսին հրատարակված գիտական հոդված" @default.
• Q33385308 description "2009年の論文" @default.
• Q33385308 description "2009年論文" @default.
• Q33385308 description "2009年論文" @default.
• Q33385308 description "2009年論文" @default.
• Q33385308 description "2009年論文" @default.
• Q33385308 description "2009年論文" @default.
• Q33385308 description "2009年论文" @default.
• Q33385308 description "2009年论文" @default.
• Q33385308 description "2009年论文" @default.
• Q33385308 description "2009年论文" @default.
• Q33385308 description "2009年论文" @default.
• Q33385308 description "2009年论文" @default.
• Q33385308 description "2009년 논문" @default.
• Q33385308 description "article científic" @default.
• Q33385308 description "article scientific" @default.
• Q33385308 description "article scientifique (publié 2009)" @default.
• Q33385308 description "articol științific" @default.
• Q33385308 description "articolo scientifico" @default.
• Q33385308 description "artigo científico (publicado na 2009)" @default.
• Q33385308 description "artigo científico (publicado na 2009)" @default.
• Q33385308 description "artigo científico" @default.
• Q33385308 description "artikull shkencor" @default.
• Q33385308 description "artikulong pang-agham" @default.
• Q33385308 description "artykuł naukowy" @default.
• Q33385308 description "artículo científico publicado en 2009" @default.
• Q33385308 description "artículu científicu espublizáu en 2009" @default.
• Q33385308 description "bilimsel makale" @default.
• Q33385308 description "bài báo khoa học" @default.
• Q33385308 description "mokslinis straipsnis" @default.
• Q33385308 description "naučni članak" @default.
• Q33385308 description "scienca artikolo" @default.
• Q33385308 description "scientific article" @default.
• Q33385308 description "teaduslik artikkel" @default.
• Q33385308 description "tieteellinen artikkeli" @default.
• Q33385308 description "tudományos cikk" @default.
• Q33385308 description "vedecký článok" @default.
• Q33385308 description "vetenskaplig artikel" @default.
• Q33385308 description "videnskabelig artikel (udgivet 2009)" @default.
• Q33385308 description "vitenskapelig artikkel" @default.
• Q33385308 description "vitskapeleg artikkel" @default.
• Q33385308 description "vědecký článek" @default.
• Q33385308 description "wetenschappelijk artikel" @default.
• Q33385308 description "wissenschaftlicher Artikel" @default.
• Q33385308 description "επιστημονικό άρθρο" @default.
• Q33385308 description "мақолаи илмӣ" @default.
• Q33385308 description "мақолаи илмӣ" @default.
• Q33385308 description "наукова стаття, опублікована в липні 2009" @default.
• Q33385308 description "научна статия" @default.
• Q33385308 description "научная статья" @default.
• Q33385308 description "научни чланак" @default.
• Q33385308 description "научни чланак" @default.
• Q33385308 description "מאמר מדעי" @default.
• Q33385308 description "سائنسی مضمون" @default.
• Q33385308 description "مقالة علمية" @default.
• Q33385308 description "مقالهٔ علمی" @default.
• Q33385308 description "২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q33385308 description "บทความทางวิทยาศาสตร์" @default.
• Q33385308 description "სამეცნიერო სტატია" @default.
• Q33385308 name "Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells" @default.
• Q33385308 name "Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells" @default.
• Q33385308 name "Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells" @default.
• Q33385308 type Item @default.
• Q33385308 label "Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells" @default.
• Q33385308 label "Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells" @default.
• Q33385308 label "Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells" @default.
• Q33385308 prefLabel "Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells" @default.
• Q33385308 prefLabel "Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells" @default.
• Q33385308 prefLabel "Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells" @default.
• Q33385308 P1433 Q33385308-10E72F95-2561-4F23-ADED-7461B7C5F2DF @default.
• Q33385308 P1476 Q33385308-7C722041-A59C-46ED-99DD-94C6ABA7ECB5 @default.
• Q33385308 P2093 Q33385308-03F3336F-9AC8-4AFB-87A6-4851B59B95AC @default.
• Q33385308 P2093 Q33385308-14AC371D-BF59-4ABF-BF32-E3C0278C7835 @default.
• Q33385308 P2093 Q33385308-37506822-CEAF-442D-A236-D367AD2BEC2A @default.
• Q33385308 P2093 Q33385308-3ABD75A1-5F2A-499F-9EE1-08A2AF541F7C @default.
• Q33385308 P2093 Q33385308-4BC85336-2462-4491-91FD-CE53F73FFCF3 @default.
• Q33385308 P2093 Q33385308-6C2CFD92-6512-4A73-A35B-B5855336F174 @default.
• Q33385308 P2093 Q33385308-6EA1CC78-8E2D-41C3-9DCA-045C2F6BE2F8 @default.
• Q33385308 P2093 Q33385308-A06ACFD2-B0C8-40B4-AFC3-7928B89088AF @default.
• Q33385308 P2093 Q33385308-ABE517DA-0118-4961-AB19-1293ADA8D869 @default.
• Q33385308 P2093 Q33385308-B506D8DA-9688-43BA-A249-E1783453AA49 @default.
• Q33385308 P2093 Q33385308-C70DCD70-A64C-4214-9E8D-493369BFB7CD @default.
• Q33385308 P2093 Q33385308-C756E740-F05E-4718-8328-5F18AF094AB2 @default.
• Q33385308 P2093 Q33385308-EEEB0375-965A-46BF-9D4B-4FFEDD3B953F @default.
• Q33385308 P2093 Q33385308-F44D2075-D404-4ABD-BAEB-82328C5284A9 @default.
• Q33385308 P2860 Q33385308-078FCF56-CA1A-4FB4-A813-CE9D422E3CF2 @default.
• Q33385308 P2860 Q33385308-1517D563-26A7-416A-8CA7-4F0F77134CBB @default.
• Q33385308 P2860 Q33385308-1AB35C62-F0EB-4376-8005-145220A9107C @default.
• Q33385308 P2860 Q33385308-446A08A7-D47D-44B4-8F14-2832F0B92220 @default.
• Q33385308 P2860 Q33385308-5C35963C-647B-4F16-89E2-1BF98699C30B @default.
• Q33385308 P2860 Q33385308-60CDAEB5-9504-417C-983A-7A2A389AF2BD @default.
• Q33385308 P2860 Q33385308-6BB89EFA-062B-4A17-BE94-1B6A9F34D8E7 @default.
• Q33385308 P2860 Q33385308-6CA99A8A-F25B-44DE-B60B-43C8EEB34273 @default.
• Q33385308 P2860 Q33385308-74EE3B82-428E-434E-BECD-CCACE9423C3B @default.
• Q33385308 P2860 Q33385308-75825F49-ADA3-4598-9C21-23B4E848A901 @default.
• Q33385308 P2860 Q33385308-7AC98A87-6606-411E-B80F-B6F39BF92330 @default.
• Q33385308 P2860 Q33385308-8A974019-9C7E-4643-BF32-E207932738AF @default.
• Q33385308 P2860 Q33385308-9F783D75-1C19-4D69-A413-C91992628938 @default.

• next